AR029808A1 - Memno-peptidos, procedimiento para su preparacion y empleo de los mismos - Google Patents

Memno-peptidos, procedimiento para su preparacion y empleo de los mismos

Info

Publication number
AR029808A1
AR029808A1 ARP010100884A ARP010100884A AR029808A1 AR 029808 A1 AR029808 A1 AR 029808A1 AR P010100884 A ARP010100884 A AR P010100884A AR P010100884 A ARP010100884 A AR P010100884A AR 029808 A1 AR029808 A1 AR 029808A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
memno
peptides
same
Prior art date
Application number
ARP010100884A
Other languages
English (en)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AR029808A1 publication Critical patent/AR029808A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invencion se refiere a nuevos derivados peptídicos, denominados memnopéptidos, de la formula general (1) en la cual R1, R2, R3, R4, R5, R6, R7, R8 y (A)n tienen los significados indicados en la presente, obtenibles mediante fermentacion de Memnoniella echinata FH 2272, DSM 13195, o de mutantes o variantes de la misma, a un procedimiento para su preparacion y al empleo de los compuestos como medicamentos, particularmente contra insuficiencias cardíacas.
ARP010100884A 2000-02-29 2001-02-27 Memno-peptidos, procedimiento para su preparacion y empleo de los mismos AR029808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
AR029808A1 true AR029808A1 (es) 2003-07-16

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100884A AR029808A1 (es) 2000-02-29 2001-02-27 Memno-peptidos, procedimiento para su preparacion y empleo de los mismos

Country Status (30)

Country Link
US (1) US6627604B2 (es)
EP (2) EP1130027A1 (es)
JP (1) JP4787449B2 (es)
KR (1) KR100997073B1 (es)
CN (1) CN1274715C (es)
AR (1) AR029808A1 (es)
AT (1) ATE313556T1 (es)
AU (2) AU5031801A (es)
BR (1) BR0108757A (es)
CA (1) CA2401032C (es)
CY (1) CY1105550T1 (es)
CZ (1) CZ303552B6 (es)
DE (1) DE60116063T2 (es)
DK (1) DK1261625T3 (es)
EE (1) EE05406B1 (es)
ES (1) ES2254394T3 (es)
HK (1) HK1052712B (es)
HR (1) HRP20020703B1 (es)
HU (1) HU228067B1 (es)
IL (2) IL151458A0 (es)
ME (1) MEP59108A (es)
MX (1) MXPA02007845A (es)
NO (1) NO329082B1 (es)
NZ (1) NZ521036A (es)
PL (1) PL206818B1 (es)
RU (1) RU2261254C2 (es)
SI (1) SI1261625T1 (es)
SK (1) SK287310B6 (es)
WO (1) WO2001064715A2 (es)
ZA (1) ZA200206841B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711157A4 (en) * 1993-08-06 1996-07-31 Smithkline Beecham Corp ENDOTHELIN RECEPTOR ANTAGONISTS
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
NO20024105L (no) 2002-10-28
IL151458A (en) 2008-08-07
JP4787449B2 (ja) 2011-10-05
HUP0204584A2 (hu) 2003-04-28
HK1052712B (zh) 2007-01-12
SK12262002A3 (sk) 2003-02-04
ME00379B (me) 2011-05-10
CN1406243A (zh) 2003-03-26
ES2254394T3 (es) 2006-06-16
HUP0204584A3 (en) 2005-09-28
MXPA02007845A (es) 2002-11-29
CN1274715C (zh) 2006-09-13
JP2004512257A (ja) 2004-04-22
ZA200206841B (en) 2003-07-03
EP1261625B1 (en) 2005-12-21
HRP20020703B1 (en) 2011-01-31
SK287310B6 (sk) 2010-06-07
DE60116063T2 (de) 2006-08-03
CA2401032A1 (en) 2001-09-07
MEP59108A (en) 2011-05-10
RU2002125877A (ru) 2004-01-10
AU2001250318B2 (en) 2005-09-08
EE05406B1 (et) 2011-04-15
PL206818B1 (pl) 2010-09-30
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
CZ20022904A3 (cs) 2002-11-13
ATE313556T1 (de) 2006-01-15
HK1052712A1 (en) 2003-09-26
DE60116063D1 (de) 2006-01-26
CZ303552B6 (cs) 2012-12-05
EE200200480A (et) 2004-02-16
WO2001064715A3 (en) 2002-03-21
US20010031857A1 (en) 2001-10-18
US6627604B2 (en) 2003-09-30
PL358300A1 (en) 2004-08-09
KR100997073B1 (ko) 2010-11-30
NZ521036A (en) 2004-02-27
DK1261625T3 (da) 2006-04-18
NO329082B1 (no) 2010-08-16
HRP20020703A2 (en) 2004-12-31
CY1105550T1 (el) 2010-07-28
IL151458A0 (en) 2003-04-10
WO2001064715A2 (en) 2001-09-07
RU2261254C2 (ru) 2005-09-27
HU228067B1 (en) 2012-09-28
EP1261625A2 (en) 2002-12-04
CA2401032C (en) 2012-04-10
BR0108757A (pt) 2002-12-10
EP1130027A1 (de) 2001-09-05
AU5031801A (en) 2001-09-12
SI1261625T1 (sl) 2006-04-30

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
MXPA03005464A (es) Agentes antivirales.
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MY129263A (en) Vaccine composition
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
WO2007052123A3 (en) Pyrazine derivatives as sodium channel modulators for the treatment of pain
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
GB0112348D0 (en) Compounds
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
BR0314352A (pt) Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
IL150061A0 (en) Purine derivatives
AR029808A1 (es) Memno-peptidos, procedimiento para su preparacion y empleo de los mismos
TW200504051A (en) Novel acridine derivatives and their use as medicaments
DE60142065D1 (de) Aliphatisch substituierte demethoxylierte hypocrelline und deren herstellung
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
MXPA03006424A (es) Novedosos derivados de 1,4-diamino-2-alquenil-benceno y colorantes que contienen dichos compuestos.
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης

Legal Events

Date Code Title Description
FG Grant, registration